Atlas market file · Equity · United States
Ecolab Inc.ECL
- Last close
- 283.46
- Change
- -0.70%
- 96-bar range
- 243.15 – 288.45
- As of
- 6 Aug 2026
Ecolab Inc. is a soap, detergents, cleang preparations, perfumes, cosmetics issuer listed as ECL on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+14.65% over the window).
Source rail: Yahoo Finance chart API (ECL). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ECL. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
ECL Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
Atlas Pro entitlement required. The release gate runs again when you request the file.
ECL public profile
Soap, detergents, cleang preparations, perfumes, cosmetics issuer. Ecolab Inc. is connected to current market context, cited company sources and its retained research file.
Ecolab Inc. trades as ECL on NYSE. Ecolab Inc. (ECL) has a latest verified close of 283.46, down 0.70%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ECL under USA Stocks and Science & Biotech Stocks for browsing.
What changed for Ecolab Inc. today
Ecolab Inc. isn’t just another soap-and-water story. It’s a $25 billion balance sheet company with $4.07 billion in revenue for Q1 2026, $432.6 million in net income, and $1.52 in diluted EPS. The firm also spent $348.5 million on capital expenditure while increasing inventories by $47.3 million and taking $27.5 million in restructuring charges. That’s the reality behind the glossy sustainability pages: a business that moves a lot of liquid chemicals, hires and fires people, and writes cheques to consultants while promising to save the planet.
What Ecolab actually does is sell water, hygiene, and infection-prevention solutions to businesses that can’t afford a single outbreak, a single fine, or a single wasted litre. Its customers include Sysco, Sodexo, and Moeve’s San Roque Energy Park, where Ecolab’s circular water solutions reportedly recycled 317 million gallons annually and cut freshwater extraction by 39%. The case studies are impressive: better water use, less waste, happier regulators. The trouble is, Ecolab’s own inventory rose by $47.3 million in the same quarter, and its Q1 2026 restructuring charges climbed to $27.5 million from $39.4 million a year earlier. Savings for the planet, costs for the P&L.
The numbers come straight from Ecolab’s 10-Q for the quarter ending 31 March 2026. Revenue from contracts with customers, excluding tax, was $4.07 billion. Net income attributable to the parent was $432.6 million. Operating income was $622.0 million. Cash and cash equivalents stood at $519.8 million, while net cash provided by operating activities was $445.9 million. Stockholders’ equity was $10.00 billion against liabilities of $15.01 billion. Diluted weighted average shares outstanding were 283.7 million, and diluted EPS was $1.52. Capital expenditure was $348.5 million, R&D expense for the full year 2025 was $202.0 million, and inventories net were $1.57 billion, up $47.3 million from the prior quarter. Special items in product and equipment cost of sales totalled $11.3 million, and restructuring charges were $27.5 million.
Ecolab’s sustainability promise is real, but the operational bill is too. The company’s ‘People, Planet and Business Health’ page outlines its mission to improve water conservation, operational performance, and productivity through outcome-based solutions. Case studies with Sysco, Sodexo, and Moeve show measurable gains: water recycling, energy savings, and safer food-contact surfaces. Yet the 10-Q shows rising inventories, rising restructuring costs, and insider trading activity on 2 July 2026. The gap between the pitch and the filing trail is measurable-and it’s widening.
The company’s latest sustainability case studies are available on its official news rails: Sysco partnership outcomes, Sodexo water and energy reductions, and Moeve’s circular water success at San Roque Energy Park. These pages prove the company has customers and projects, but they don’t prove margin sustainability or execution discipline. For that, the 10-Q is the harder read. The sustainability stories are compelling; the filings are candid. The market can decide which story it prefers.
Ecolab’s 10-Q filing for Q1 2026 is the primary source for the financials cited above. The company’s sustainability and success stories are hosted on its official product and news rails. Insider trading activity is recorded in multiple Form 4 filings dated 2 July 2026, while the 13G filing dated 16 July 2026 updates a passive investor’s stake. These sources collectively outline a company with real customers, real products, and real financial mechanics-some of which move in opposite directions.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ECL technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ECL
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ECL research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ECL FAQ
What is Ecolab Inc. (ECL)?Ecolab Inc. (ECL) has a latest verified close of 283.46, down 0.70%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Ecolab Inc. (ECL) has a latest verified close of 283.46, down 0.70%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ECL?Ecolab Inc. (ECL) has a latest verified close of 283.46, down 0.70%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Ecolab Inc. (ECL) has a latest verified close of 283.46, down 0.70%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ECL under USA Stocks and Science & Biotech Stocks for browsing.
How often is the ECL page updated?The ECL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ECL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ECL?The ECL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:ECL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The ECL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:ECL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ECL?Yes. The workstation can open ECL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ECL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ECL page investment advice?No. The ECL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ECL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
ECL
Equity · evidence first